Friday, October 30, 2026
HomeHealthBuzzy longevity supplement flops in major Parkinson's trial

Buzzy longevity supplement flops in major Parkinson’s trial

A popular supplement commonly marketed for improving longevity failed to show meaningful benefits for people with early-stage Parkinson’s in a new study.

Read the full story at New York Post »

info@sportsmedical.news

RELATED ARTICLES
- Advertisment -

Most Popular

Recent Comments

Translate »